Adaptive Biotechnologies Corporation
DE ˙ MUN ˙ US00650F1093
13,58 € ↑0,76 (5,89%)
2026-06-04
DEL PRIS
SecurityDE:1HM / Adaptive Biotechnologies Corporation
InstitutionCrewe Advisors LLC
Latest Disclosed Ownership11,543 shares
Latest Disclosed Value $ 160,217
Crewe Advisors LLC ownership in 1HM / Adaptive Biotechnologies Corporation

On May 7, 2026 - Crewe Advisors LLC filed a 13F-HR form disclosing ownership of 11,543 shares of Adaptive Biotechnologies Corporation (DE:1HM) valued at $128,589 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 11,543 shares of Adaptive Biotechnologies Corporation. This represents a change in shares of 0.00% during the quarter. The current value of the position is $156,754 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 11,543 0 0.00 160 -14.44 0.0137
2026-01-16 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 11,543 0 0.00 187 8.72 0.0166
2025-11-13 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 11,543 0 0.00 173 28.36 0.0165
2025-07-30 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 11,543 0 0.00 134 57.65 0.0190
2025-04-23 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 11,543 0 0.00 86 23.19 0.0121
2025-01-27 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 11,543 0 0.00 69 16.95 0.0095
2024-11-12 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 11,543 -47,595 -80.48 59 -72.43 0.0069
2024-07-29 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,138 0 0.00 214 13.23 0.0240
2024-05-14 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,138 -600 -1.00 190 -35.27 0.0221
2024-02-09 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,738 0 0.00 293 -10.15 0.0463
2023-11-09 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,738 0 0.00 326 -18.75 0.0563
2023-07-28 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,738 0 0.00 401 -24.10 0.0563
2023-05-12 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,738 0 0.00 527 15.57 0.0769
2023-02-08 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,738 -113 -0.19 456 7.04 0.0724
2022-11-14 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,851 0 0.00 426 -11.98 0.0770
2022-08-02 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,851 613 1.03 484 -41.12 0.1069
2022-04-27 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,238 100 0.17 822 -50.45 0.1604
2022-02-10 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,138 0 0.00 1,659 -17.46 0.3373
2021-10-29 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,138 0 0.00 2,010 -16.80 0.4750
2021-08-11 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,138 0 0.00 2,416 1.47 0.5994
2021-04-21 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,138 0 0.00 2,381 -31.91 0.5906
2021-01-27 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 59,138 -16,870 -22.20 3,497 -5.38 1.3997
2020-10-13 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 76,008 -5,410 -6.64 3,696 -6.17 1.7335
2020-07-24 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 81,418 -11,582 -12.45 3,939 52.44 1.9242
2020-05-07 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 93,000 93,000 2,584 1.5418
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.